Home/Filings/4/0000917520-24-000109
4//SEC Filing

De Witte Jan 4

Accession 0000917520-24-000109

CIK 0000917520other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 4:33 PM ET

Size

8.4 KB

Accession

0000917520-24-000109

Insider Transaction Report

Form 4
Period: 2024-11-01
De Witte Jan
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2024-11-01+9,81428,164 total
  • Tax Payment

    Common Stock

    2024-11-01$19.28/sh4,262$82,17123,902 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-11-019,814120,466 total
    Exercise: $0.00Common Stock (9,814 underlying)
Footnotes (1)
  • [F1]On November 1, 2022, the reporting person was granted a restricted stock unit award which vests in three equal annual installments on the first, second and third anniversaries of the grant date of 11/01/2022 and which convert into shares of common stock on a one-for-one basis. The second installment vested on 11/1/2024.

Issuer

INTEGRA LIFESCIENCES HOLDINGS CORP

CIK 0000917520

Entity typeother

Related Parties

1
  • filerCIK 0001776929

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:33 PM ET
Size
8.4 KB